Inst Diagnosti Stock Current Valuation
| INDISA Stock | CLP 1,591 4.40 0.28% |
Valuation analysis of Inst Diagnosti helps investors to measure Inst Diagnosti's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Inst Diagnosti's price fluctuation is very steady at this time. Calculation of the real value of Inst Diagnosti is based on 3 months time horizon. Increasing Inst Diagnosti's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Inst Diagnosti is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Inst Stock. However, Inst Diagnosti's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1590.6 | Real 1145.23 | Hype 1590.6 | Naive 1634.37 |
The real value of Inst Stock, also known as its intrinsic value, is the underlying worth of Inst Diagnosti Company, which is reflected in its stock price. It is based on Inst Diagnosti's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Inst Diagnosti's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Inst Diagnosti helps investors to forecast how Inst stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Inst Diagnosti more accurately as focusing exclusively on Inst Diagnosti's fundamentals will not take into account other important factors: Inst Diagnosti Company Current Valuation Analysis
Inst Diagnosti's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Inst Diagnosti Current Valuation | 329.99 B |
Most of Inst Diagnosti's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Inst Diagnosti is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Inst Diagnosti has a Current Valuation of 329.99 B. This is much higher than that of the Healthcare sector and significantly higher than that of the Medical Care industry. The current valuation for all Chile stocks is significantly lower than that of the firm.
Inst Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Inst Diagnosti's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Inst Diagnosti could also be used in its relative valuation, which is a method of valuing Inst Diagnosti by comparing valuation metrics of similar companies.Inst Diagnosti is currently under evaluation in current valuation category among its peers.
Inst Fundamentals
| Return On Equity | 0.19 | |||
| Return On Asset | 0.0489 | |||
| Profit Margin | 0.1 % | |||
| Operating Margin | 0.1 % | |||
| Current Valuation | 329.99 B | |||
| Shares Outstanding | 140.93 M | |||
| Shares Owned By Insiders | 32.76 % | |||
| Shares Owned By Institutions | 45.10 % | |||
| Price To Earning | 18.54 X | |||
| Price To Book | 2.28 X | |||
| Price To Sales | 1.21 X | |||
| Revenue | 188.54 B | |||
| Gross Profit | 50.69 B | |||
| EBITDA | 28.05 B | |||
| Net Income | 20.65 B | |||
| Cash And Equivalents | 18.3 B | |||
| Cash Per Share | 129.85 X | |||
| Total Debt | 33.85 B | |||
| Debt To Equity | 69.60 % | |||
| Current Ratio | 1.57 X | |||
| Book Value Per Share | 722.14 X | |||
| Cash Flow From Operations | 14.83 B | |||
| Earnings Per Share | 135.00 X | |||
| Target Price | 2100.0 | |||
| Number Of Employees | 2.98 K | |||
| Beta | 0.58 | |||
| Market Capitalization | 216 B | |||
| Total Asset | 230.88 B | |||
| Z Score | 3.6 | |||
| Annual Yield | 0.05 % | |||
| Five Year Return | 1.33 % | |||
| Net Asset | 230.88 B | |||
| Last Dividend Paid | 73.2 |
About Inst Diagnosti Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Inst Diagnosti's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Inst Diagnosti using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Inst Diagnosti based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Inst Diagnosti
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Inst Diagnosti position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inst Diagnosti will appreciate offsetting losses from the drop in the long position's value.Moving together with Inst Stock
Moving against Inst Stock
The ability to find closely correlated positions to Inst Diagnosti could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Inst Diagnosti when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Inst Diagnosti - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Inst Diagnosti to buy it.
The correlation of Inst Diagnosti is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Inst Diagnosti moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Inst Diagnosti moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Inst Diagnosti can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Inst Stock
Inst Diagnosti financial ratios help investors to determine whether Inst Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Inst with respect to the benefits of owning Inst Diagnosti security.